Bracco A-C-D Solution Modified™ (Anticoagulant Citrate Dextrose Solution Modified) is indicated for use with Chromitope Sodium (Sodium Chromate Cr 51 Injection) in the labeling of red blood cells for intravenous administration and in vitro diagnostic tests.¹

As in the use of any radioactive material, care should be taken to minimize the radiation exposure to the patient consistent with proper patient management and to ensure minimum radiation exposure to occupational workers. Radiopharmaceuticals should be used only by physicians who are qualified by training and experience in the safe use and handling of radionuclides and whose experience and training have been approved by the appropriate government agency authorized to license the use of radionuclides.

Download pdf file	Package Insert	Material Safety Data Sheet
Bracco A-C-D